APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody-Drug Conjugate Analysis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antibody-Drug Conjugate Analysis Market Analysis and Forecast 2026-2032

15 April 2026187 pages

Choose your research edition.

Industry ResearchAntibody-Drug Conjugate Analysis Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody-Drug Conjugate Analysis Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Antibody-Drug Conjugate Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody-Drug Conjugate Analysis Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Antibody-Drug Conjugate Analysis Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Antibody-Drug Conjugate Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antibody-Drug Conjugate Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antibody-Drug Conjugate Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antibody-Drug Conjugate Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antibody-Drug Conjugate Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antibody-Drug Conjugate Analysis include SGS SA, Sciex, Bioinformatics Solutions Inc., Intertek, Agilent, Biofidus AG and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antibody-Drug Conjugate Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antibody-Drug Conjugate Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for Antibody-Drug Conjugate Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibody-Drug Conjugate Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antibody-Drug Conjugate Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antibody-Drug Conjugate Analysis revenue, projected growth trends, production technology, application and end-user industry.

Antibody-Drug Conjugate Analysis Segment by Company

SGS SA

Sciex

Bioinformatics Solutions Inc.

Intertek

Agilent

Biofidus AG

Creative Biolabs

Antibody-Drug Conjugate Analysis Segment by Type

Qualitative Analysis

Quantitative Analysis

Antibody-Drug Conjugate Analysis Segment by Application

Pharmaceuticals

Scientific Research

Other

Antibody-Drug Conjugate Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody-Drug Conjugate Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody-Drug Conjugate Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody-Drug Conjugate Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antibody-Drug Conjugate Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antibody-Drug Conjugate Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody-Drug Conjugate Analysis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antibody-Drug Conjugate Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Qualitative Analysis Major Player Table 3. Quantitative Analysis Major Player Table 4. Global Antibody-Drug Conjugate Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals Major Player Table 6. Scientific Research Major Player Table 7. Other Major Player Table 8. Antibody-Drug Conjugate Analysis Industry Trends Table 9. Antibody-Drug Conjugate Analysis Industry Drivers Table 10. Antibody-Drug Conjugate Analysis Industry Opportunities and Challenges Table 11. Antibody-Drug Conjugate Analysis Industry Restraints Table 12. Global Antibody-Drug Conjugate Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Antibody-Drug Conjugate Analysis Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Antibody-Drug Conjugate Analysis Market Share by Region (2021-2026) Table 15. Global Antibody-Drug Conjugate Analysis Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Antibody-Drug Conjugate Analysis Market Share by Region (2027-2032) Table 17. Global Antibody-Drug Conjugate Analysis Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Players (2021-2026) Table 19. Global Antibody-Drug Conjugate Analysis Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Antibody-Drug Conjugate Analysis Key Players Headquarters & Area Served Table 21. Global Antibody-Drug Conjugate Analysis Players, Product Type & Application Table 22. Global Antibody-Drug Conjugate Analysis Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Antibody-Drug Conjugate Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Antibody-Drug Conjugate Analysis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Type (2021-2026) Table 29. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Type (2027-2032) Table 30. Global Antibody-Drug Conjugate Analysis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Application (2021-2026) Table 34. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Application (2027-2032) Table 35. SGS SA Company Information Table 36. SGS SA Business Overview Table 37. SGS SA Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. SGS SA Antibody-Drug Conjugate Analysis Product Portfolio Table 39. SGS SA Recent Development Table 40. Sciex Company Information Table 41. Sciex Business Overview Table 42. Sciex Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sciex Antibody-Drug Conjugate Analysis Product Portfolio Table 44. Sciex Recent Development Table 45. Bioinformatics Solutions Inc. Company Information Table 46. Bioinformatics Solutions Inc. Business Overview Table 47. Bioinformatics Solutions Inc. Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bioinformatics Solutions Inc. Antibody-Drug Conjugate Analysis Product Portfolio Table 49. Bioinformatics Solutions Inc. Recent Development Table 50. Intertek Company Information Table 51. Intertek Business Overview Table 52. Intertek Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Intertek Antibody-Drug Conjugate Analysis Product Portfolio Table 54. Intertek Recent Development Table 55. Agilent Company Information Table 56. Agilent Business Overview Table 57. Agilent Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Agilent Antibody-Drug Conjugate Analysis Product Portfolio Table 59. Agilent Recent Development Table 60. Biofidus AG Company Information Table 61. Biofidus AG Business Overview Table 62. Biofidus AG Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Biofidus AG Antibody-Drug Conjugate Analysis Product Portfolio Table 64. Biofidus AG Recent Development Table 65. Creative Biolabs Company Information Table 66. Creative Biolabs Business Overview Table 67. Creative Biolabs Antibody-Drug Conjugate Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Creative Biolabs Antibody-Drug Conjugate Analysis Product Portfolio Table 69. Creative Biolabs Recent Development Table 70. North America Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 71. North America Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 72. North America Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Antibody-Drug Conjugate Analysis Revenue by Country (US$ Million) & (2027-2032) Table 77. Europe Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 78. Europe Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 79. Europe Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 80. Europe Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 81. Europe Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026) & (US$ Million) Table 83. Europe Antibody-Drug Conjugate Analysis Revenue by Country (US$ Million) & (2027-2032) Table 84. China Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 85. China Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 86. China Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 87. China Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 89. Asia Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 90. Asia Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 91. Asia Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 92. Asia Antibody-Drug Conjugate Analysis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Antibody-Drug Conjugate Analysis Revenue by Region (US$ Million) & (2021-2026) Table 94. Asia Antibody-Drug Conjugate Analysis Revenue by Region (US$ Million) & (2027-2032) Table 95. SAMEA Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026) & (US$ Million) Table 96. SAMEA Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032) & (US$ Million) Table 97. SAMEA Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026) & (US$ Million) Table 98. SAMEA Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032) & (US$ Million) Table 99. SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026) & (US$ Million) Table 101. SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (US$ Million) & (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Antibody-Drug Conjugate Analysis Image Figure 2. Global Antibody-Drug Conjugate Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody-Drug Conjugate Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Qualitative Analysis Image Figure 5. Quantitative Analysis Image Figure 6. Global Antibody-Drug Conjugate Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antibody-Drug Conjugate Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Antibody-Drug Conjugate Analysis Market Size (US$ Million) & (2021-2032) Figure 12. Global Antibody-Drug Conjugate Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antibody-Drug Conjugate Analysis Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Antibody-Drug Conjugate Analysis Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Antibody-Drug Conjugate Analysis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antibody-Drug Conjugate Analysis Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Type (2021-2032) Figure 19. Global Antibody-Drug Conjugate Analysis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Antibody-Drug Conjugate Analysis Revenue Market Share by Application (2021-2032) Figure 22. North America Antibody-Drug Conjugate Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032) Figure 24. North America Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032) Figure 25. North America Antibody-Drug Conjugate Analysis Revenue Share by Country (2021-2032) Figure 26. United States Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Antibody-Drug Conjugate Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032) Figure 31. Europe Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032) Figure 32. Europe Antibody-Drug Conjugate Analysis Revenue Share by Country (2021-2032) Figure 33. Germany Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Antibody-Drug Conjugate Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032) Figure 43. China Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032) Figure 44. Asia Antibody-Drug Conjugate Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032) Figure 46. Asia Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032) Figure 47. Asia Antibody-Drug Conjugate Analysis Revenue Share by Region (2021-2032) Figure 48. Japan Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Antibody-Drug Conjugate Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032) Figure 56. SAMEA Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032) Figure 57. SAMEA Antibody-Drug Conjugate Analysis Revenue Share by Country (2021-2032) Figure 58. Brazil Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Antibody-Drug Conjugate Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Qualitative Analysis
  • Quantitative Analysis
Applications
  • Pharmaceuticals
  • Scientific Research
  • Other
Companies covered
  • SGS SA
  • Sciex
  • Bioinformatics Solutions Inc.
  • Intertek
  • Agilent
  • Biofidus AG
  • Creative Biolabs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antibody-Drug Conjugate Analysis Market by Type
  3. 1.2.1 Global Antibody-Drug Conjugate Analysis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Qualitative Analysis
  5. 1.2.3 Quantitative Analysis
  6. 1.3 Antibody-Drug Conjugate Analysis Market by Application
  7. 1.3.1 Global Antibody-Drug Conjugate Analysis Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Antibody-Drug Conjugate Analysis Market Dynamics
  1. 2.1 Antibody-Drug Conjugate Analysis Industry Trends
  2. 2.2 Antibody-Drug Conjugate Analysis Industry Drivers
  3. 2.3 Antibody-Drug Conjugate Analysis Industry Opportunities and Challenges
  4. 2.4 Antibody-Drug Conjugate Analysis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antibody-Drug Conjugate Analysis Market Perspective (2021-2032)
  2. 3.2 Global Antibody-Drug Conjugate Analysis Growth Trends by Region
  3. 3.2.1 Global Antibody-Drug Conjugate Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antibody-Drug Conjugate Analysis Market Size by Region (2021-2026)
  5. 3.2.3 Global Antibody-Drug Conjugate Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antibody-Drug Conjugate Analysis Revenue by Players
  2. 4.1.1 Global Antibody-Drug Conjugate Analysis Revenue by Players (2021-2026)
  3. 4.1.2 Global Antibody-Drug Conjugate Analysis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antibody-Drug Conjugate Analysis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antibody-Drug Conjugate Analysis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antibody-Drug Conjugate Analysis Key Players Headquarters & Area Served
  7. 4.4 Global Antibody-Drug Conjugate Analysis Players, Product Type & Application
  8. 4.5 Global Antibody-Drug Conjugate Analysis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antibody-Drug Conjugate Analysis Market CR5 and HHI
  11. 4.6.3 2025 Antibody-Drug Conjugate Analysis Tier 1, Tier 2, and Tier 3
5 Antibody-Drug Conjugate Analysis Market Size by Type
  1. 5.1 Global Antibody-Drug Conjugate Analysis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 5.3 Global Antibody-Drug Conjugate Analysis Revenue Market Share by Type (2021-2032)
6 Antibody-Drug Conjugate Analysis Market Size by Application
  1. 6.1 Global Antibody-Drug Conjugate Analysis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  3. 6.3 Global Antibody-Drug Conjugate Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS SA
  2. 7.1.1 SGS SA Company Information
  3. 7.1.2 SGS SA Business Overview
  4. 7.1.3 SGS SA Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS SA Antibody-Drug Conjugate Analysis Product Portfolio
  6. 7.1.5 SGS SA Recent Developments
  7. 7.2 Sciex
  8. 7.2.1 Sciex Company Information
  9. 7.2.2 Sciex Business Overview
  10. 7.2.3 Sciex Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sciex Antibody-Drug Conjugate Analysis Product Portfolio
  12. 7.2.5 Sciex Recent Developments
  13. 7.3 Bioinformatics Solutions Inc.
  14. 7.3.1 Bioinformatics Solutions Inc. Company Information
  15. 7.3.2 Bioinformatics Solutions Inc. Business Overview
  16. 7.3.3 Bioinformatics Solutions Inc. Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bioinformatics Solutions Inc. Antibody-Drug Conjugate Analysis Product Portfolio
  18. 7.3.5 Bioinformatics Solutions Inc. Recent Developments
  19. 7.4 Intertek
  20. 7.4.1 Intertek Company Information
  21. 7.4.2 Intertek Business Overview
  22. 7.4.3 Intertek Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Intertek Antibody-Drug Conjugate Analysis Product Portfolio
  24. 7.4.5 Intertek Recent Developments
  25. 7.5 Agilent
  26. 7.5.1 Agilent Company Information
  27. 7.5.2 Agilent Business Overview
  28. 7.5.3 Agilent Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Agilent Antibody-Drug Conjugate Analysis Product Portfolio
  30. 7.5.5 Agilent Recent Developments
  31. 7.6 Biofidus AG
  32. 7.6.1 Biofidus AG Company Information
  33. 7.6.2 Biofidus AG Business Overview
  34. 7.6.3 Biofidus AG Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biofidus AG Antibody-Drug Conjugate Analysis Product Portfolio
  36. 7.6.5 Biofidus AG Recent Developments
  37. 7.7 Creative Biolabs
  38. 7.7.1 Creative Biolabs Company Information
  39. 7.7.2 Creative Biolabs Business Overview
  40. 7.7.3 Creative Biolabs Antibody-Drug Conjugate Analysis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biolabs Antibody-Drug Conjugate Analysis Product Portfolio
  42. 7.7.5 Creative Biolabs Recent Developments
8 North America
  1. 8.1 North America Antibody-Drug Conjugate Analysis Revenue (2021-2032)
  2. 8.2 North America Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 8.2.1 North America Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026)
  4. 8.2.2 North America Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032)
  5. 8.3 North America Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032)
  6. 8.4 North America Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  7. 8.4.1 North America Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026)
  8. 8.4.2 North America Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032)
  9. 8.5 North America Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032)
  10. 8.6 North America Antibody-Drug Conjugate Analysis Revenue by Country
  11. 8.6.1 North America Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026)
  13. 8.6.3 North America Antibody-Drug Conjugate Analysis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antibody-Drug Conjugate Analysis Revenue (2021-2032)
  2. 9.2 Europe Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032)
  5. 9.3 Europe Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032)
  9. 9.5 Europe Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antibody-Drug Conjugate Analysis Revenue by Country
  11. 9.6.1 Europe Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antibody-Drug Conjugate Analysis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antibody-Drug Conjugate Analysis Revenue (2021-2032)
  2. 10.2 China Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 10.2.1 China Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026)
  4. 10.2.2 China Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032)
  5. 10.3 China Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032)
  6. 10.4 China Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  7. 10.4.1 China Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026)
  8. 10.4.2 China Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032)
  9. 10.5 China Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antibody-Drug Conjugate Analysis Revenue (2021-2032)
  2. 11.2 Asia Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032)
  5. 11.3 Asia Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032)
  9. 11.5 Asia Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antibody-Drug Conjugate Analysis Revenue by Country
  11. 11.6.1 Asia Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antibody-Drug Conjugate Analysis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antibody-Drug Conjugate Analysis Revenue (2021-2032)
  2. 12.2 SAMEA Antibody-Drug Conjugate Analysis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antibody-Drug Conjugate Analysis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antibody-Drug Conjugate Analysis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antibody-Drug Conjugate Analysis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antibody-Drug Conjugate Analysis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antibody-Drug Conjugate Analysis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antibody-Drug Conjugate Analysis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antibody-Drug Conjugate Analysis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antibody-Drug Conjugate Analysis Revenue by Country
  11. 12.6.1 SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antibody-Drug Conjugate Analysis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst